{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:54:13Z","timestamp":1791122053367,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Henan Province Medical Science and Technology Key Research Program - Joint Youth Project with Provincial and Ministry Support","award":["SBGJ202403042"],"award-info":[{"award-number":["SBGJ202403042"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11596-1","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T13:50:33Z","timestamp":1779976233000},"page":"8395-8421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Design, synthesis, and biological evaluation of glycyrrhetinic acid\u2013cinnamamide derivatives as HMGB1\/TLR4 pathway inhibitors for sepsis-induced liver injury"],"prefix":"10.1007","volume":"30","author":[{"given":"Jiao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhian","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"issue":"12","key":"11596_CR1","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1007\/s00134-024-07694-z","volume":"50","author":"I Martin-Loeches","year":"2024","unstructured":"Martin-Loeches I, Singer M, Leone M (2024) Sepsis: key insights, future directions, and immediate goals. a review and expert opinion. Intensive Care Med 50(12):2043\u20132049","journal-title":"Intensive Care Med"},{"key":"11596_CR2","doi-asserted-by":"publisher","first-page":"1577105","DOI":"10.3389\/fimmu.2025.1577105","volume":"16","author":"X Gao","year":"2025","unstructured":"Gao X, Cai S, Li X, Wu G (2025) Sepsis-induced immunosuppression: mechanisms, biomarkers and immunotherapy. Front Immunol 16:1577105","journal-title":"Front Immunol"},{"key":"11596_CR3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jare.2024.04.004","volume":"69","author":"J Zhu","year":"2025","unstructured":"Zhu J, Jin Z, Wang J, Wu Z, Xu T, Tong G, Shen E, Fan J, Jiang C, Wang J et al (2025) FGF21 ameliorates septic liver injury by restraining proinflammatory macrophages activation through the autophagy\/HIF-1\u03b1 axis. J Adv Res 69:477\u2013494","journal-title":"J Adv Res"},{"issue":"1","key":"11596_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/aps.2011.151","volume":"33","author":"G Gong","year":"2012","unstructured":"Gong G, Yuan L-b, Hu L, Wu W, Yin L, Hou J-l, Liu Y-h (2012) Zhou L-s: Glycyrrhizin attenuates rat ischemic spinal cord injury by suppressing inflammatory cytokines and HMGB1. Acta Pharmacol Sin 33(1):11\u201318","journal-title":"Acta Pharmacol Sin"},{"key":"11596_CR5","doi-asserted-by":"publisher","first-page":"114294","DOI":"10.1016\/j.intimp.2025.114294","volume":"150","author":"Q Sun","year":"2025","unstructured":"Sun Q, Li L, Li J, Li SY, Zhang Y, Chen XS, Liu SS, Hua ZY (2025) Glycyrrhizin alleviates brain injury in necrotizing enterocolitis model mice by suppressing HMGB1\/TLR4 pathway. Int Immunopharmacol 150:114294","journal-title":"Int Immunopharmacol"},{"key":"11596_CR6","doi-asserted-by":"publisher","first-page":"2395557","DOI":"10.1155\/mi\/2395557","volume":"2025","author":"N Zhu","year":"2025","unstructured":"Zhu N, Ge X, Zhang L, Chen X, Xiang W, Mei Q (2025) HMGB1 Exacerbates intestinal barrier damage by inducing ferroptosis through the TLR4\/NF-\u03baB\/GPX4 pathway in ulcerative colitis. Mediators Inflamm 2025:2395557","journal-title":"Mediators Inflamm"},{"issue":"1","key":"11596_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1161\/CIRCULATIONAHA.123.065202","volume":"150","author":"X Guo","year":"2024","unstructured":"Guo X, Zhong J, Zhao Y, Fu Y, Sun LY, Yuan A, Liu J, Chen AF, Pu J (2024) LXR\u03b1 promotes abdominal aortic aneurysm formation through UHRF1 epigenetic modification of miR-26b-3p. Circulation 150(1):30\u201346","journal-title":"Circulation"},{"issue":"1","key":"11596_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.yexcr.2018.05.012","volume":"369","author":"X Sun","year":"2018","unstructured":"Sun X, Zeng H, Wang Q, Yu Q, Wu J, Feng Y, Deng P, Zhang H (2018) Glycyrrhizin ameliorates inflammatory pain by inhibiting microglial activation-mediated inflammatory response via blockage of the HMGB1-TLR4-NF-kB pathway. Exp Cell Res 369(1):112\u2013119","journal-title":"Exp Cell Res"},{"key":"11596_CR9","doi-asserted-by":"crossref","unstructured":"Wang X, Zhou Y, Liu Y, Mo T, Chen Z, Zhang Y, Yang L, Liu P (2025) Baicalein reduces pyroptosis of acinar cells in hyperlipidemic acute pancreatitis by inhibiting m1 polarization of macrophages via the HMGB1\/TLR4\/NLRP3 Pathway. Inflammation","DOI":"10.1007\/s10753-025-02254-z"},{"key":"11596_CR10","doi-asserted-by":"publisher","first-page":"e2408047","DOI":"10.4014\/jmb.2408.08047","volume":"35","author":"H Kim","year":"2024","unstructured":"Kim H, Kim KS, Lee YC, Cho JH (2024) Chloroform extract from fermented viola mandshurica regulates lps-induced inflammation response in RAW 264.7 cells by inhibiting iNOS and COX-2. J Microbiol Biotechnol 35:e2408047","journal-title":"J Microbiol Biotechnol"},{"key":"11596_CR11","doi-asserted-by":"publisher","first-page":"103521","DOI":"10.1016\/j.redox.2025.103521","volume":"80","author":"MS Kwak","year":"2025","unstructured":"Kwak MS, Han M, Lee YJ, Choi S, Kim J, Park IH, Shin JS (2025) ROS anchor PAMPs-mediated extracellular HMGB1 self-association and its dimerization enhances pro-inflammatory signaling. Redox Biol 80:103521","journal-title":"Redox Biol"},{"key":"11596_CR12","doi-asserted-by":"publisher","first-page":"118671","DOI":"10.1016\/j.jep.2024.118671","volume":"335","author":"ER Puppala","year":"2024","unstructured":"Puppala ER, Prasad N, Prakash AN, Abubakar M, Syamprasad NP, Gangasani JK, Naidu VGM (2024) Mesua assamica (King & Prain) kosterm. bark ethanolic extract attenuates rheumatoid arthritis via down-regulating TLR4\/NF-\u03baB\/COX-2\/iNOS and activation of Nrf2\/HO-1 pathways: a comprehensive study on in-vitro and in-vivo models. J Ethnopharmacol 335:118671","journal-title":"J Ethnopharmacol"},{"key":"11596_CR13","doi-asserted-by":"publisher","first-page":"1265172","DOI":"10.3389\/fphar.2023.1265172","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Sheng Z, Xiao J, Li Y, Huang J, Jia J, Zeng X, Li L (2023) Advances in the roles of glycyrrhizic acid in cancer therapy. Front Pharmacol 14:1265172","journal-title":"Front Pharmacol"},{"issue":"4","key":"11596_CR14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1080\/08923973.2021.1939371","volume":"43","author":"ZH Zhu","year":"2021","unstructured":"Zhu ZH, Li X, He LF, Cai HF, Ye B, Wu ZM (2021) Glycyrrhizic acid, as an inhibitor of HMGB1, alleviates bleomycin-induced pulmonary toxicity in mice through the MAPK and Smad3 pathways. Immunopharmacol Immunotoxicol 43(4):461\u2013470","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"1","key":"11596_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11481-024-10128-8","volume":"19","author":"C Yu","year":"2024","unstructured":"Yu C, Xiang Y, Zhang M, Wen J, Duan X, Wang L, Deng G, Fang P (2024) Glycyrrhizic acid alleviates semen strychni-induced neurotoxicity through the inhibition of hmgb1 phosphorylation and inflammatory responses. J Neuroimmune Pharmacol 19(1):21","journal-title":"J Neuroimmune Pharmacol"},{"key":"11596_CR16","doi-asserted-by":"publisher","first-page":"e856","DOI":"10.1016\/j.wneu.2021.11.085","volume":"158","author":"Z Wu","year":"2022","unstructured":"Wu Z, Wang Z, Xie Z, Zhu H, Li C, Xie S, Zhou W, Zhang Z, Li M (2022) Glycyrrhizic acid attenuates the inflammatory response after spinal cord injury by inhibiting high mobility group box-1 protein through the p38\/Jun N-terminal kinase signaling pathway. World Neurosurg 158:e856\u2013e864","journal-title":"World Neurosurg"},{"issue":"12","key":"11596_CR17","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/aps.2012.112","volume":"33","author":"CL Zhai","year":"2012","unstructured":"Zhai CL, Zhang MQ, Zhang Y, Xu HX, Wang JM, An GP, Wang YY, Li L (2012) Glycyrrhizin protects rat heart against ischemia-reperfusion injury through blockade of HMGB1-dependent phospho-JNK\/Bax pathway. Acta Pharmacol Sin 33(12):1477\u20131487","journal-title":"Acta Pharmacol Sin"},{"issue":"10","key":"11596_CR18","doi-asserted-by":"publisher","first-page":"826","DOI":"10.2174\/1389557519666190119111125","volume":"19","author":"ZG Sun","year":"2019","unstructured":"Sun ZG, Zhao TT, Lu N, Yang YA, Zhu HL (2019) Research progress of glycyrrhizic acid on antiviral activity. Mini Rev Med Chem 19(10):826\u2013832","journal-title":"Mini Rev Med Chem"},{"issue":"7","key":"11596_CR19","doi-asserted-by":"publisher","first-page":"e2200052","DOI":"10.1002\/ardp.202200052","volume":"355","author":"LS Feng","year":"2022","unstructured":"Feng LS, Cheng JB, Su WQ, Li HZ, Xiao T, Chen DA, Zhang ZL (2022) Cinnamic acid hybrids as anticancer agents: A mini-review. Arch Pharm 355(7):e2200052","journal-title":"Arch Pharm"},{"key":"11596_CR20","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.2147\/IDR.S413242","volume":"16","author":"Q Lu","year":"2023","unstructured":"Lu Q, Han W, Wen D, Guo P, Liu Y, Wu Z, Fu S, Ye C, Wang X, Qiu Y (2023) 18\u03b2-Glycyrrhetinic Acid Alleviates P. multocida-induced vascular endothelial inflammation by PARP1-mediated NF-\u03baB and HMGB1 signalling suppression in PIEC cells. Infect drug Resist 16:4201\u20134212","journal-title":"Infect drug Resist"},{"key":"11596_CR21","doi-asserted-by":"crossref","unstructured":"Marco LMa, E. Bianchi a,c, Giovanna Musco a,c (2008) The binding domain of the HMGB1 inhibitor carbenoxolone: theory and experiment. Chemical Phys Lett 456:236\u2013242","DOI":"10.1016\/j.cplett.2008.03.022"},{"issue":"15","key":"11596_CR22","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.2174\/1871520619666190411114718","volume":"19","author":"FF El-Senduny","year":"2019","unstructured":"El-Senduny FF, Zidane MM, Youssef MM, Badria FA (2019) An approach to treatment of liver cancer by novel glycyrrhizin derivative. Anticancer Agents Med Chem 19(15):1863\u20131873","journal-title":"Anticancer Agents Med Chem"},{"issue":"9","key":"11596_CR23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2131\/jts.47.381","volume":"47","author":"M Sawai","year":"2022","unstructured":"Sawai M, Miyauchi Y, Ishida T, Takechi S (2022) Dihydropyrazine suppresses TLR4-dependent inflammatory responses by blocking MAPK signaling in human hepatoma HepG2 cells. J Toxicol Sci 47(9):381\u2013387","journal-title":"J Toxicol Sci"},{"issue":"6","key":"11596_CR24","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/ptr.6358","volume":"33","author":"H Xuguang","year":"2019","unstructured":"Xuguang H, Aofei T, Tao L, Longyan Z, Weijian B, Jiao G (2019) Hesperidin ameliorates insulin resistance by regulating the IRS1-GLUT2 pathway via TLR4 in HepG2 cells. Phytother Res 33(6):1697\u20131705","journal-title":"Phytother Res"},{"issue":"4","key":"11596_CR25","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S2095-4964(17)60350-9","volume":"15","author":"BH Han","year":"2017","unstructured":"Han BH, Lee YJ, Yoon JJ, Choi ES, Namgung S, Jin XJ, Jeong DH, Kang DG, Lee HS (2017) Hwangryunhaedoktang exerts anti-inflammation on LPS-induced NO production by suppressing MAPK and NF- \u03baB activation in RAW264.7 macrophages. J Integr Med 15(4):326\u2013336","journal-title":"J Integr Med"},{"key":"11596_CR26","doi-asserted-by":"publisher","first-page":"114636","DOI":"10.1016\/j.jep.2021.114636","volume":"282","author":"ZH Lin","year":"2022","unstructured":"Lin ZH, Hu J, Shi H, Liaw CC, Qiu WL, Hsu WH, Lin TY (2022) Water extract of medicinal ink (WEMI) attenuates lipopolysaccharide-induced NO production of Raw264.7 cells via downregulating JAK2\/STAT3-mediated iNOS expression. J Ethnopharmacol 282:114636","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"11596_CR27","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s12026-021-09210-7","volume":"69","author":"S Jiang","year":"2021","unstructured":"Jiang S, Wang R, Han L, Kuerban K, Ye L, Pan S, Li S, Yuan Y (2021) Activation of autophagy reverses gemcitabine-induced immune inhibition of RAW264.7 macrophages by promoting TNF-\u03b1, IL-6 and MHC-II expression. Immunol Res 69(4):352\u2013362","journal-title":"Immunol Res"},{"issue":"2","key":"11596_CR28","first-page":"179","volume":"120","author":"TJ Standiford","year":"1992","unstructured":"Standiford TJ, Strieter RM (1992) TNF and IL-1 in sepsis: good cytokines gone bad. J Lab Clin Med 120(2):179\u2013180","journal-title":"J Lab Clin Med"},{"key":"11596_CR29","doi-asserted-by":"crossref","unstructured":"Gao Z, Dai H, Zhang Q, Yang F, Bu C, Chen S (2024) Hydroxytyrosol Alleviates Acute Liver Injury by Inhibiting the TNF-\u03b1\/PI3K\/AKT Signaling Pathway via Targeting TNF-\u03b1 Signaling. Int J Mol Sci 25(23)","DOI":"10.3390\/ijms252312844"},{"issue":"9","key":"11596_CR30","doi-asserted-by":"publisher","first-page":"7815","DOI":"10.1007\/s11033-023-08666-0","volume":"50","author":"SS Tamber","year":"2023","unstructured":"Tamber SS, Bansal P, Sharma S, Singh RB, Sharma R (2023) Biomarkers of liver diseases. Mol Biol Rep 50(9):7815\u20137823","journal-title":"Mol Biol Rep"},{"issue":"3","key":"11596_CR31","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jhep.2013.03.033","volume":"59","author":"C Brenner","year":"2013","unstructured":"Brenner C, Galluzzi L, Kepp O, Kroemer G (2013) Decoding cell death signals in liver inflammation. J Hepatol 59(3):583\u2013594","journal-title":"J Hepatol"},{"key":"11596_CR32","doi-asserted-by":"crossref","unstructured":"Li M, Ge Q, Du H, Lin S (2021) Tricholoma matsutake-derived peptides ameliorate inflammation and mitochondrial dysfunction in RAW264.7 Macrophages by Modulating the NF-\u03baB\/COX-2 Pathway. Foods 10(11)","DOI":"10.3390\/foods10112680"},{"issue":"9","key":"11596_CR33","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1002\/hep4.1979","volume":"6","author":"A Roy","year":"2022","unstructured":"Roy A, Verma N, Singh S, Pradhan P, Taneja S, Singh M (2022) Immune-mediated liver injury following COVID-19 vaccination: A systematic review. Hepatol Commun 6(9):2513\u20132522","journal-title":"Hepatol Commun"},{"issue":"1","key":"11596_CR34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/bmc.1082","volume":"23","author":"Q Zou","year":"2009","unstructured":"Zou Q, Wei P, Li J, Ge ZX, Ouyang P (2009) Simultaneous determination of 18alpha- and 18beta-glycyrrhetic acid in human plasma by LC-ESI-MS and its application to pharmacokinetics. Biomedical chromatography: BMC 23(1):54\u201362","journal-title":"Biomedical chromatography: BMC"},{"issue":"1","key":"11596_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s42826-024-00205-7","volume":"40","author":"Y Jiao","year":"2024","unstructured":"Jiao Y, Tong CSW, Zhao L, Zhang Y, Nicholls JM, Rainer TH (2024) Intraperitoneal versus intranasal administration of lipopolysaccharide in causing sepsis severity in a murine model: a preliminary comparison. Lab Anim Res 40(1):18","journal-title":"Lab Anim Res"},{"issue":"1","key":"11596_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2045-9912-1-15","volume":"1","author":"Y Liu","year":"2011","unstructured":"Liu Y, Liu W, Sun X, Li R, Sun Q, Cai J, Kang Z, Lv S, Zhang JH, Zhang W (2011) Hydrogen saline offers neuroprotection by reducing oxidative stress in a focal cerebral ischemia-reperfusion rat model. Med Gas Res 1(1):15","journal-title":"Med Gas Res"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11596-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11596-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11596-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:47:49Z","timestamp":1791121669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11596-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["11596"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11596-1","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"16 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known conflict of financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}